Clinical Fear of Cancer Recurrence:
Development and Validation of a Clinical Interview, Self-Report Measure, and Screening Tool
-
Clinical Psychology Ph.D Candidate
B.A., Psychology, University of Ottawa, 2021
Her research interests focus on clinical fear of cancer recurrence, including the development of measures and interventions for fear of cancer recurrence as well as the impact of fear of cancer recurrence on caregivers of cancer patients or survivors.
Fear of cancer recurrence (FCR) is a common experience for cancer survivors who fear their cancer may come back in the same or a different part of the body (Lebel et al., 2016). Although almost 49% of cancer survivors clinical levels of FCR (Simard et al., 2013), there currently exists no measure used by healthcare professionals to detect clinical FCR.
Thus, Dr Sophie Lebel, Ph.D candidate Brittany Mutsaers, and Lauriane Giguère are currently creating and validating three measures for healthcare professional to use to detect clinical FCR. Once finalized, the Ottawa Clinical Fear of Recurrence – Interview (OCFR-I), the Ottawa Clinical Fear of Recurrence – Measure (OCFR-M), and Ottawa Clinical Fear of Recurrence – Screener (OCFR-S) will be validated in three parts.
One will consist in completing the OCFR-M and OCFR-S along with six other measures. Around 230 participants will be recruited. The second stage, which will be optional (n = 50), will consist in completing the OCFR-M and OCFR-S again after a two-week period.Finally, the third stage, which will also be optional, will consist in completing the OCFR-I and three other interviews (n = 50). Recrutement is currently underway.
This study will take place in Spring 2022. Should you be interested in participating or seek more information, email us at fcrstudy@toh.ca